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The Notch signalling regulator Fringe acts in the Golgi apparatus
and requires the glycosyltransferase signature motif DxD
Sean Munro and Matthew Freeman
Background: Signalling via the Notch receptor is a key regulator of many
developmental processes. The differential responsiveness of Notch-expressing
cells to the ligands Delta and Serrate is controlled by Fringe, itself essential for
normal patterning in Drosophila and vertebrates. The mechanism of Fringe
action, however, is not known. The protein has an amino-terminal hydrophobic
stretch resembling a cleaved signal peptide, which has led to the widespread
assumption that it is a secreted signalling molecule. It also has distant
homology to bacterial glycosyltransferases, although it is not clear if this reflects
a shared enzymatic activity, or merely a related structure.
Results: We report that a functional epitope-tagged form of Drosophila Fringe
was localised in the Golgi apparatus. When the putative signal peptide was
replaced by a confirmed one, Fringe no longer accumulated in the Golgi, but
was instead efficiently secreted. This change in localisation dramatically
reduced its biological activity, implying that the wild-type protein normally acts
inside the cell. We show that Fringe specifically binds the nucleoside
diphosphate UDP, a feature of many glycosyltransferases. Furthermore, specific
mutation of a DxD motif (in the single-letter amino acid code where x is any
amino acid), a hallmark of most glycosyltransferases that use nucleoside
diphosphate sugars, did not affect the Golgi localisation of the protein but
completely eliminated in vivo activity.
Conclusions: These results indicate that Fringe does not exert its effects
outside of the cell, but rather acts in the Golgi apparatus, apparently as a
glycosyltransferase. They suggest that alteration in receptor glycosylation can
regulate the relative efficiency of different ligands.
Background
The Notch family of receptors controls a broad range of cell
fate decisions in vertebrates and invertebrates; it is thus a
key regulator of development. The receptors themselves
have been well conserved and consist of an extracellular
ligand-binding domain with multiple tandemly arranged
EGF-like motifs and also characteristic LN repeats. In a
process still not fully understood, ligand binding induces
the proteolytic cleavage of the Notch intracellular domain,
which then translocates to the nucleus, where it participates
in a transcriptional activation complex [1,2]. Drosophila
Notch is activated by two well established ligands, Delta
and Serrate, although there are other extracellular proteins
that have been proposed to also bind to, and modulate, the
receptor [3,4]. Delta and Serrate are similar in structure,
each having a transmembrane domain and, like the recep-
tor, a tandem array of EGF domains [5–7]. 
In both the eye and wing imaginal discs, an interplay of
Delta and Serrate is required for the generation of organis-
ing centres that coordinate the growth and patterning of
the discs [8–10]. This has been best studied in the wing,
where Notch signalling at the boundary between the dorsal
and ventral compartments triggers the expression of
margin-specific genes, including the secreted protein
Wingless, which acts over a long distance to regulate wing
development. This crucial activation of Notch at the wing
margin is controlled by Serrate, which is expressed only on
the dorsal side of the margin, and Delta, whose expression
is limited to the ventral side of the margin. Genetic evi-
dence shows that Serrate efficiently activates Notch only in
the ventral cells (that is, where it is not itself expressed)
and, similarly, Delta activates Notch only in the dorsal
cells. These restrictions ensure that Notch activity is
limited to only the cells at the boundary between the dorsal
and ventral compartments. The molecular mechanism that
spatially restricts the function of the two ligands, which
appear to be functionally equivalent, is not understood but
is dependent on the product of the fringe gene [11–16].
Like Notch and its ligands, Fringe has been well conserved
through evolution, as has its role in modulating Notch sig-
nalling at important developmental boundaries [17–23].
Fringe has frequently been proposed to be a secreted
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signalling protein by virtue of a putative signal peptide
near its amino terminus (for example [4,14,24–26]); it is
also cysteine-rich, leading to the proposal that it might
form a type of ‘cysteine-knot’ structure, typical of several
growth factors [14]. An alternative view was suggested
when it was discovered that Fringe proteins have some
sequence similarities to a family of bacterial glycosyltrans-
ferases: it was proposed that Fringe may be a secreted gly-
cosyltransferase that acts by regulating the glycosylation of
proteins involved in Notch signalling [27].
These two hypotheses, Fringe as a secreted signal or
Fringe as an extracellular glycosyltransferase, both con-
tinue to be advocated and are sufficiently distinct to cause
confusion in the interpretation of data relating to Fringe
function. We have tried to clarify this issue and here
report that Drosophila Fringe is a Golgi-localised protein
that has the hallmarks of a glycosyltransferase: it binds
UDP specifically and mutation of a single amino acid in
the putative enzyme active site is sufficient to abolish its
function. Moreover, our evidence indicates that Fringe
does not function extracellularly. 
Results
Drosophila Fringe is localised in the Golgi apparatus
We made a Myc-tagged version of Fringe and expressed it
in transgenic Drosophila using the UAS–Gal4 system [28]
(Figure 1). Ectopic expression of the Myc-tagged Fringe
confirmed that the protein was functional (see below).
When uniformly expressed in embryos under the control
of armadillo–Gal4, the Myc-tagged Fringe was found by
immunofluorescence to be in punctate structures in all
cells (Figure 2a,b). Drosophila cells are relatively small,
and the Golgi apparatus is not organised into the charac-
teristic perinuclear cluster of ribbons typical of mam-
malian cells [29,30]. To determine whether the punctate
structures were Golgi, we double-labelled embryos with
a Golgi-specific monoclonal antibody [29]. Fringe co-
localised with the Golgi marker precisely, demonstrating
that Fringe principally resides in the Golgi apparatus.
We then looked at the location of Fringe expressed in
the large polyploid cells of the larval salivary gland,
under the control of the AB1–Gal4 line (Figure 2c). The
cells around the duct of the gland stained well with the
Golgi marker and we found them to have very large
amounts of Golgi, appropriate for their secretory func-
tion. In these cells, too, Fringe was localised specifically
to the Golgi apparatus. 
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Figure 1
Structure of Fringe and SP–Fringe. (a) Organisation of Fringe, with the
amino-terminal hydrophobic region and the conserved DxD motif
indicated. (b) Amino-terminal sequences of Fringe and SP–Fringe, a
derivative in which the hydrophobic amino terminus of Fringe is
replaced with the signal peptide of the secreted protein Argos (lower
case). The hydrophobic stretch at the Fringe amino terminus is boxed,
and the putative signal peptide cleavage site proposed to exist in Fringe
[14] and Argos is marked with open and filled arrows, respectively.
(c) Anti-Myc immunoblot of proteins prepared from transgenic
Drosophila embryos expressing the indicated Myc-tagged versions of
Fringe. Drosophila Fringe is predicted to contain several sites for
addition of O-linked glycans (between residues 72 and 145) and the
protein migrates as a heterogeneous band with an apparent size
greater than predicted, suggesting that these sites are being modified.
(b)
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Figure 2
Wild-type Myc-tagged Fringe is located in the Golgi apparatus.
Confocal images of tissue stained with anti-Myc, to visualise Fringe,
(left panels), anti-120 kDa, a Golgi-specific marker (middle panels) and
the merged image (right panels; Fringe in green, Golgi marker in red).
The scale bars represent 5 µm. (a,b) Fringe protein, shown at two
magnifications, is located in punctate structures in embryos and
co-localises precisely with the Golgi marker. Note that there is some
variability in the extent of Fringe staining between individual Golgi
structures; we do not know whether this signifies some distinction
between individual Golgi stacks, or if this is an artefact based, for
example, on variable penetration of the anti-Myc antibody. (c) Cells
around the duct at the anterior tip of the salivary gland have very large
amounts of Golgi apparatus. Fringe is seen only in the Golgi of these
relatively large cells.
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A bona fide signal peptide causes Fringe to be secreted
A stretch of hydrophobic amino acids near the amino ter-
minus is a conserved feature of Drosophila and vertebrate
Fringe proteins and has led to the proposal that these pro-
teins are secreted [4,14,24–26]. In order to test this, we
replaced this putative signal peptide with that from a well
established secreted protein, Argos, an antagonistic ligand
of the EGF receptor [31] (Figure 1b). Western blotting of
protein extracts from embryos expressing this chimera
(SP–Fringe) showed that it is smaller than the full-length
protein (Figure 1c). If the hydrophobic stretch from full-
length Fringe were being removed by signal peptidase, it
would be predicted to leave a protein that is a few residues
smaller than that produced when the Argos signal peptide
is removed from SP–Fringe (Figure 1b). The larger size of
wild-type Fringe implies that it is not in fact cleaved at the
putative signal peptide, but instead the protein remains
attached to its amino-terminal hydrophobic stretch.
We then examined the localisation of Myc-tagged
SP–Fringe in transgenic Drosophila. In contrast to the
wild-type protein, SP–Fringe is not found in the Golgi
apparatus, but instead has a marked extracellular appear-
ance. In embryos, SP–Fringe outlines cells and appears
to fill the extracellular space (Figure 3a,b). Even more
dramatically, SP–Fringe is secreted into the lumen of the
salivary gland duct (Figure 3c). In the embryo, we do not
see any clear intracellular staining of SP–Fringe,
although in the salivary gland there is weak staining,
which at least partially co-localises with the Golgi appara-
tus, and which we suspect is the secreted protein in
transit through the secretory pathway.
Secreted Fringe has reduced activity
It is, in principle, possible that a small amount of wild-
type Fringe is released from the Golgi apparatus and
secreted, and this could be the functional form of the
protein. We tested this by comparing the in vivo activity of
wild-type Fringe with that of SP–Fringe. The assay used
was the ectopic expression of Fringe in the eye and the
wing. At the dorsal–ventral boundary of both the eye and
wing imaginal discs, a juxtaposition of Fringe-expressing
and non-expressing cells is required to establish a narrow
domain of Notch signalling; when this boundary of Fringe
is disrupted by its ectopic expression, the Notch sig-
nalling is lost and the organising centre abolished. This
leads to developmental defects, including reduction in the
size of the eye and wing [8,11]. We expressed each
UAS–fringe construct under the control of several Gal4
drivers: eyeless–Gal4, patched–Gal4, scalloped–Gal4 and
klumpfuss–Gal4. Although, when expressed at very high
levels, SP–Fringe and the wild-type protein caused severe
and indistinguishable abnormalities, at lower expression
levels, SP–Fringe caused much less severe defects than
the wild-type protein. For example, under the control of
patched–Gal4, wild-type Fringe causes a reduction in size
of the eye and a disruption of the regular array of omma-
tidia that comprise the compound eye (Figure 4a); in con-
trast, SP–Fringe expressed under the control of the same
driver barely disrupts eye development (Figure 4b). When
the genes are expressed at slightly higher levels, for
example in the eye, under the control of eyeless–Gal4 at
18°C or in the wing under the control of klumpfuss–Gal4,
SP–Fringe does have detectable activity (Figure 4d,f), but
it is much less than the wild-type protein (Figure 4c,e).
These results imply that forcing Fringe to be secreted
substantially reduces its ability to function. We suspect
that the weak residual activity of SP–Fringe is due to its
transient presence in the Golgi apparatus as it moves
through the secretory pathway (see below).
In summary, the results described above show that wild-
type Fringe is a Golgi-localised protein and that this locali-
sation is necessary for its efficient action: secretion of Fringe
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Figure 3
SP–Fringe is efficiently secreted. Confocal images of tissue stained
with anti-Myc, to visualise Fringe (left panels), anti-120 kDa, a
Golgi-specific marker (middle panels) and the merged image (right
panels; Fringe in green, Golgi marker in red). The scale bar represents
5 µm. (a,b) In embryos, SP–Fringe expressed under the control of
armadillo–Gal4 (green) is located extracellularly, where it outlines cells,
shown at two magnifications. It appears to fill the extracellular space
and not to be tightly associated with the plasma membranes. No
co-localisation with the Golgi apparatus is detectable. (c) SP–Fringe
expressed under the control of AB1–Gal4 is efficiently secreted from
salivary gland duct cells and accumulates in the lumen of the duct. In
these cells, low levels of Fringe can be seen internally, some of which
co-localises with the Golgi marker. We believe this intracellular fraction
is in transit through the secretory pathway (see text).
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impairs its function. These observations are inconsistent
with a model in which a putative secreted fraction of the
protein is the active pool, and we therefore propose that
Fringe functions in the Golgi apparatus.
Fringe binds specifically to UDP
The Golgi localisation of Fringe raises the question of how
it acts in this organelle to affect Notch signalling. The
Golgi apparatus is where the wide array of complex glycan
structures are added to core carbohydrates, which are
attached to secreted proteins in the endoplasmic reticulum
and early Golgi. As Fringe has distant homology to known
glycosyltransferases, an appealing possibility is that it is
itself a Golgi glycosyltransferase. One of the characteristics
of Golgi glycosyltransferases is that, like many other glyco-
syltransferases, they use nucleoside sugars as donors, and
in the majority of cases this nucleoside is UDP. The pres-
ence of a UDP-binding site in Fringe was thus investigated
by UV crosslinking. Myc-tagged SP–Fringe was expressed
in COS cells and the medium collected and concentrated.
Figure 5a shows that a Myc-tagged 70 kDa protein appears
in the medium of cells expressing the SP–Fringe plasmid.
When a radiolabelled photoactivatable UDP analogue was
incubated with the control medium, several minor bands
were labelled in a UV-dependent manner. In the
SP–Fringe-expressing cells, a strongly labelled 70 kDa
band was also present, indicating that the SP–Fringe
product was labelled. This labelling was competed by
unlabelled UDP, but not by GDP, CDP or ADP
(Figure 5b). Wild-type Fringe also showed crosslinking to
UDP, with a similar sensitivity to competition (Figure 5c).
Thus, it appears that Fringe specifically binds to UDP, a
characteristic of many glycosyltransferases. Moreover, the
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Figure 5
Labelling of Fringe with a photoactivatable analogue of UDP.
(a) Protein gels of medium from COS cells transfected with plasmids
expressing either SP–Fringe (Fg) or a control protein (–). Medium
was either loaded directly and analysed by Coomassie blue stain
(prot) or by blotting with an anti-Myc antibody, or first incubated with
[β-32P]4-thioUDP and exposed to UV for 5 min, as indicated, prior to
gel running and autoradiography. The abundant 67 kDa band in the
medium is bovine serum albumin, which migrates close to
Myc-tagged SP–Fringe and distorts the latter band slightly, but
clearly does not crosslink to [β-32P]4-thioUDP. (b) Autoradiographs of
SP–Fringe-containing medium exposed to [β-32P]4-thioUDP and UV
light for 2 min in the presence of the increasing amounts of the
indicated nucleoside diphosphates. (c) Autoradiographs of Myc-tagged
SP–Fringe or wild-type Fringe immunoprecipitated and exposed to
[β-32P]4-thioUDP and UV light for 1 min in the presence of the
indicated concentrations of UDP. (d) Autoradiographs of medium
containing either SP–Fringe (DDD) or SP–ADD-Fringe (ADD) exposed
to [β-32P]4-thioUDP and UV light for the indicated time.
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Figure 4
SP–Fringe has substantially reduced activity. (a,b) Adult Drosophila eyes
expressing (a) wild-type Fringe and (b) SP–Fringe under the control of
patched–Gal4, which is expressed at low levels in the eye. The wild-type
protein disrupts eye development significantly, whereas SP–Fringe at this
level of expression has no effect. (c,d) When expressed at higher levels,
under the control of eyeless–Gal4 at 18°C, it is clear that (d) SP–Fringe
does retain some activity, but much less than (c) the wild-type protein.
(e,f) A similar effect is seen in the wing, when the genes are expressed
under the control of klumpfuss–Gal4: (e) wild-type Fringe causes major
developmental defects, whereas (f) SP–Fringe has only a mild effect
(compare with the wild-type wing phenotype in Figure 6f). 
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unaltered ability of SP–Fringe to bind UDP, along with its
efficient secretion, indicates that its reduced biological
activity is not simply caused by misfolding, but rather
reflects its transient presence in the Golgi apparatus. When
known glycosyltransferases are converted to secreted
forms, they have been observed to continue to modify sub-
strates but at a reduced level [32,33].
The DxD active-site motif of glycosyltransferases is
required for Fringe function
In the region most conserved within the Fringe family,
which is also where there is some similarity to more dis-
tantly related glycosyltransferases, there is a DxD motif, a
hallmark of the catalytic site of many nucleoside diphos-
phate-binding glycosyltransferases [34,35]. We tested
whether this predicted active site was required for Fringe
function by mutating the first aspartate (236) to an
alanine (DDD to ADD; Figure 6a), and assaying the
function and localisation of the Myc-tagged ADD-Fringe.
When expressed in embryos or salivary gland duct cells,
ADD-Fringe was localised in the Golgi (Figure 6b,c),
indistinguishably from the wild-type Fringe, suggesting
that the mutant protein is stably expressed and normally
folded. Consistent with this, ADD-Fringe binds UDP
indistinguishably from the wild type (Figure 5d). The
DxD motif is believed to serve to coordinate a manganese
ion required for catalysis, whereas residues elsewhere are
responsible for binding the nucleotide and sugar in an
enzyme-specific manner [35]. However, when the biolog-
ical activity of ADD-Fringe was assayed by ectopic
expression with the same range of Gal4 expression drivers
as described above, the ADD-Fringe mutant was com-
pletely inert under all conditions, even when expressed at
high levels, for example under the control of eyeless–Gal4
in the eye, or klumpfuss–Gal4 in the wing (Figure 6d–g).
Even the strongest wing driver, patched–Gal4, failed to
produce a phenotype when used to express ADD-Fringe
(data not shown). Therefore, a single amino acid alter-
ation in the putative glycosyltransferase active site abol-
ishes all Fringe activity.
Discussion
The protein Fringe has been found in many systems to
have a critical role in modulating the response of the Notch
receptor to different ligands; in Drosophila its function is to
allow the receptor to discriminate between very similar
ligands, Delta and Serrate. However, the mechanism by
which it exerts this effect is unknown. A hydrophobic
stretch at the amino terminus of Fringe resembling a
cleaved signal peptide led to the hypothesis that Fringe is
itself a secreted signalling molecule (for example
[4,14,24–26]). An alternative possibility, that the protein is
secreted but has an enzymatic role, was suggested by the
distant structural relationship between Fringe and bacterial
glycosyltransferases [27]. In this paper we report that
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Figure 6
ADD-Fringe has no activity. (a) Alignment of Fringes showing the
conserved DxD motif (filled arrowheads), which is typically flanked by
residues that are mostly hydrophobic (circles) [34]. The open
arrowhead indicates Asp236 mutated to alanine in ADD-Fringe. Fringe
sequences shown are from Drosophila, grasshopper, mouse (Mo),
chicken (Ch), Xenopus (Xe), salamander (Sa), and two sequences
from Caenorhabditis elegans (Ce) that show the closest relationship to
Fringe are also included. (b,c) Confocal images of tissue stained with
anti-Myc, to visualise Fringe (left panels), anti-120 kDa, a Golgi-specific
marker (middle panels) and the merged image (right panels; Fringe in
green, Golgi marker in red). ADD-Fringe (green), in which the putative
glycosyltransferase active site is mutated, is localised normally in the
Golgi apparatus (red) of (b) the embryo and (c) the salivary gland duct
cells; the organisation of the triptychs is as in Figures 2 and 3; scale
bars represent 5 µm. (d) ADD-Fringe is completely inactive when
expressed at high levels in the eye under the control of eyeless–Gal4
at 18°C. (e) Under the same conditions, wild-type Fringe expression
causes the eye to be dramatically reduced in size. (f) Similarly, high-
level expression of ADD-Fringe, under the control of klumpfuss–Gal4,
has no effect on wing development: the wing is phenotypically wild-
type. (g) In contrast, wild type Fringe expressed in the same way
severely disrupts wing development.
Fringe is localised and functions in the Golgi apparatus and
has the characteristics of many families of glycosyltrans-
ferases that use nucleoside diphosphate sugars. The sim-
plest interpretation of our results is that Fringe is a
Golgi-localised glycosyltransferase. Although distinct from
both previous models, we discuss below how this interpre-
tation can be reconciled with previous studies.
The suggestion that Fringe is secreted came from the
amino-terminal hydrophobic stretch, which was predicted to
be a leader peptide [14,25]. Golgi glycosyltransferases are,
almost without exception, Type II membrane proteins with
a single transmembrane domain within the first 5–50
residues of the amino terminus [36]. Because the transmem-
brane domains of Golgi proteins are usually shorter than
those of plasma membrane proteins [37], their amino-termi-
nal regions can appear similar to signal peptides. Indeed, the
best current signal-peptide prediction programmes incor-
rectly predict known mammalian glycosyltransferases to
have cleaved amino termini (S.M., unpublished observa-
tions). The fact that, when attached to a confirmed signal
peptide, Fringe is secreted and has a smaller apparent size,
strongly suggests that the amino-terminal hydrophobic
stretch is not normally cleaved, but rather is a transmem-
brane domain typical of Golgi glycosyltransferases. A previ-
ous examination of Fringe expressed in transgenic flies
concluded that the protein was being secreted on the basis
that it could be detected outside of the expression domain
of the GAL4 expression driver being used [11]. This ‘extra-
cellular’ Fringe appeared in a punctate pattern strikingly
similar to the Golgi localisation described here, raising the
possibility that it was in fact weak ectopic expression of
the protein, caused by leakiness of the Gal4 driver. Fur-
thermore, even if a small amount of Fringe is secreted, we
have shown that forcing its secretion dramatically reduces
its activity, indicating that it is the intracellular form,
rather than the secreted form that regulates Notch sig-
nalling. An intracellular site of action for Fringe is also
easier to reconcile with the protein’s observed cell auton-
omy in regulating Notch [11]. 
Fringe has been previously noted to share some sequence
similarity with glycosyltransferases [27], and in this paper
we provide evidence that this homology reflects an homol-
ogous function rather than simply a related structure.
Fringe specifically binds the nucleoside diphosphate UDP
and is inactivated by mutation of its conserved DxD
sequence, a conserved active-site motif shared by many
families of glycosyltransferases that use nucleoside diphos-
phate sugars [34,35,38]. Glycosyltransferase activity is
again more consistent with a Golgi site of action, as nucleo-
side diphosphate sugars are unlikely to reach a significant
concentration in the extracellular space. 
Overall, our data are hard to reconcile with Fringe being a
secreted signalling protein, but instead strongly favour it
being a Golgi-localised glycosyltransferase. How then
could such an activity explain the regulation of Notch sig-
nalling? The simplest explanation is that Fringe glycosy-
lates Notch itself. Fringe is expressed only in a subset of
cells, indicating that it is not involved in widespread
glycan modifications. However, Notch contains over
thirty EGF repeats, and in mammalian cells two sets of
unusual O-linked sugar structures specific to EGF
domains, initiated by either glucose or fucose, have been
identified [39]. Consensus sequences for these modifica-
tions are conserved between the EGF repeats of
Drosophila and mammalian Notch proteins, and the modi-
fications have been found on human Notch1 [40]. Fringe
has recently been reported to bind Notch [24] and, inter-
estingly, the fucosyltransferase responsible for initiating
O-linked fucosylation binds tightly to an EGF-repeat-
containing substrate [41]. Highly protein-specific modifi-
cation may well require high-affinity interactions with
substrates. Of course, formal proof of the glycosyltrans-
ferase function of Fringe will require in vitro enzyme
studies but, nevertheless, we consider that the evidence
presented here makes this model compelling.
Specific modification by Fringe of one or more of the O-
linked structures on the Notch EGF repeats could alter
the binding affinity of the ligands Delta and Serrate.
Specifically, genetic evidence implies that Serrate binding
and/or activation of Notch would be inhibited by Fringe-
mediated glycosylation, whereas Delta binding and/or
activation would be enhanced. This prediction should be
testable in future in vitro studies. Delta and Serrate both
bind EGF repeats 11 and 12 of Notch [42], the latter of
which contains a well conserved site for O-linked glucosy-
lation. However, the situation may be more complex, as
Abruptex mutations in Notch that map to EGF repeats 24,
25, 27 or 29 have interestingly been found to be insensi-
tive to modulation by Fringe [43]. It may be that recogni-
tion or modification of many of the Notch repeats is
critical for affecting ligand binding.
A role for Fringe in Notch glycosylation would imply that
site-specific glycosylation is a means by which cells can
modulate the ligand-responsiveness of specific receptors.
This conclusion clearly has widespread potential signifi-
cance for understanding the interactions between extra-
cellular ligands and their receptors. Fringe is well
conserved between Drosophila and mammals, and mam-
malian Fringes seem likely to have similar roles to that of
the Drosophila protein. Indeed, mouse Manic Fringe, one
of the three closely related mammalian Fringes, is also
located in the Golgi (S.M., unpublished observations). It
remains to be established whether the principle of modu-
lating receptor specificity by glycosylation extends to
further signalling systems, but our results suggest that it is
a good explanation for the mechanism by which Fringe
regulates Notch signalling. 
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Materials and methods
Cloning and constructs
Drosophila Fringe cDNA was amplified by PCR and cloned with a triple
Myc tag so that the carboxyl terminus of the protein was extended by
the residues GTGAGAGA(EQKLISEEDLG)3AG. Mutation of Asp236
to alanine, and insertion of a site for attachment of the Argos signal
peptide were also performed by PCR, with all amplified products
checked by sequencing. For expression in flies, tagged proteins were
cloned into the P-element vector pUAST [28]. For expression in COS
cells, the Myc-tagged versions of Fringe, SP–Fringe and SP–ADD-
Fringe were cloned into SMH3, a vector with an adenovirus major late
promoter and a SV40 replication origin, to make plasmids SADFgM1,
SADFgM3 and SADFgM4, respectively. 
Fly stocks
The following Gal4 expression drivers were used to misexpress the
fringe constructs: AB1–Gal4 (an uncharacterised salivary gland driver),
armadillo–Gal4, eyeless–Gal4, klumpfuss–Gal4, patched–Gal4
and scalloped–Gal4. All are described in Flybase
(http://fly.ebi.ac.uk:7081/).
Histology 
Embryos were immunostained by standard protocols [44]; salivary
glands were fixed in 4% paraformaldehyde and stained by standard
techniques in the presence of 0.1% Triton X-100. The following anti-
bodies were used: rabbit anti-Myc (Santa Cruz Biotechnology) at
1:500, and anti-120 kDa [29], which is a marker for Drosophila Golgi
apparatus. Alexa-594 (red) and Alexa-488 (green)-conjugated sec-
ondary antibodies from Molecular Probes were used at 1:200. Scan-
ning electron microscopy was performed by standard techniques [45].
UV crosslinking
To prepare soluble Fringe, COS cells in 10 cm plates were transfected
with either SADFgM3, SADFgM4, or a control plasmid (Fugene,
Roche). At 24 h after transfection, cells were rinsed once with serum-
free medium (Optimem, Life Technologies), and 3.5 ml serum-free
medium applied per plate. After 24 h, medium was collected, cleared
by centrifugation (3000g, 10 min), concentrated 20-fold (Centriprep
YM-10, Amicon) and dialysed against GT2 buffer (50 mM 2-[N-
morpholino]ethanesulphonic acid pH 6.8, 50 mM NaCl, 10 mM MnCl2,
20% glycerol), all steps at 4°C. After clarification (10,000g, 10 min),
concentrated medium was stored at –70°C until further use. To
prepare wild-type Fringe, COS cells were transfected as above with
SADFgM1 and 44 h post-transfection scraped into PBS, pelleted
(1000g, 5 min) and lysed in 250 µl lysis buffer per plate (1% Triton X-
100, 150 mM NaCl, 25 mM Tris–HCl pH 7.4, 1 mM EDTA, 1 mM
phenylmethylsulphonyl fluoride). After centrifugation (10,000g, 10 min)
agarose beads coupled to the anti-Myc monoclonal 9E10 were added
to the supernatant, rolled for 3 h, washed four times in lysis buffer and
resuspended in GT2 buffer containing 1% Triton X-100 (25 µl per
plate), all steps at 4°C. Myc-tagged SP–Fringe was immunoprecipi-
tated from concentrated medium, prepared as above and diluted
sixfold into lysis buffer.
Phosphorylation of 4-thioUMP to prepare [β-32P]4-thioUDP was based
on previous methods [46,47]. Briefly, a 10 µl reaction containing
0.5 mM 4-thioUMP (Sigma), 40 mM Tris–HCl pH 7.4, 22 mM MgCl2,
50 mM DTT and 80 µCi [γ-32P]ATP (3000 Ci/mmol, Amersham) and
7.5 milliunits of nucleoside monophosphate kinase (Roche) was incu-
bated at 20°C for 60 min and then stored at –70°C until further use. 
For UV-crosslinking, 25 µl reactions in GT2 buffer, containing 20 µl of
concentrated cell medium or 10 µl immunoprecipitated beads, and
0.1 µl of above kinase reaction, 1 mg/ml soybean trypsin inhibitor and,
if present, unlabelled competitor nucleoside diphosphate, were placed
in wells of a 96-well plate on ice. UV exposure was with a Blak-Ray
B100AP lamp (365 nM filter, UV Products), and then 25 µl 2× SDS
buffer was added, samples heated to 65°C and 20 µl separated by
SDS–PAGE. Gels were fixed, stained with Coomassie blue, dried onto
paper and exposed to film or phosphorimager screen for 8–24 h.
Acknowledgements
We thank Vivek Malhotra for his gift of anti-Golgi monoclonal antibody;
Alfonso Martinez-Arias for fly stocks; Andy Newman for help with UV-
crosslinking; and Catherine Rabouille for advice on Drosophila Golgi.
Richard Smith provided excellent technical assistance.
References
1. Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: cell fate
control and signal integration in development. Science 1999,
284:770-776. 
2. Egan SE, St-Pierre B, Leow CC: Notch receptors, partners and
regulators: from conserved domains to powerful functions.
Curr Top Microbiol Immunol 1998, 228:273-324. 
3. Nye JS, Kopan R: Developmental signaling: Vertebrate ligands for
Notch. Curr Biol 1995, 5:966-969. 
4. Panin VM, Irvine KD: Modulators of Notch signaling. Semin Cell
Dev Biol 1998, 9:609-617. 
5. Thomas U, Speicher SA, Knust E: The Drosophila gene Serrate
encodes an EGF-like transmembrane protein with a complex
expression pattern in embryos and wing discs. Development 1991,
111:749-761. 
6. Kopczynski CC, Alton AK, Fechtel K, Kooh PJ, Muscavitch MAT:
Delta, a Drosophila neurogenic gene, is transcriptionally complex
and encodes a protein related to blood coagulation factors and
epidermal growth factor of vertebrates. Genes Dev 1988,
2:1723-1735. 
7. Fleming RJ, Scottgale TN, Diederich RJ, Artavanis-Tsakonas S:
The gene Serrate encodes a putative EGF-like transmembrane
protein essential for proper ectodermal development in
Drosophila melanogaster. Genes Dev 1990, 4:2188-2201. 
8. Dominguez M, de Celis JF: A dorsal/ventral boundary established
by Notch controls growth and polarity in the Drosophila eye.
Nature 1998, 396:276-278. 
9. de Celis JF, Garcia-Bellido A, Bray SJ: Activation and function of
Notch at the dorsal-ventral boundary of the wing imaginal disc.
Development 1996, 122:359-369. 
10. Diaz-Benjumea FJ, Cohen SM: Serrate signals through Notch to
establish a Wingless-dependent organizer at the dorsal/ventral
compartment boundary of the Drosophila wing. Development
1995, 121:4215-4225. 
11. Panin VM, Papayannopoulos V, Wilson R, Irvine KD: Fringe modulates
Notch-ligand interactions. Nature 1997, 387:908-912. 
12. Fleming RJ, Gu Y, Hukriede NA: Serrate-mediated activation of
Notch is specifically blocked by the product of the gene fringe in
the dorsal compartment of the Drosophila wing imaginal disc.
Development 1997, 124:2973-2981. 
13. Irvine KD: Fringe, Notch, and making developmental boundaries.
Curr Opin Genet Dev 1999, 9:434-441. 
14. Irvine KD, Wieschaus E: Fringe, a boundary-specific signaling
molecule, mediates interactions between dorsal and ventral cells
during Drosophila wing development. Cell 1994, 79:595-606. 
15. Kim J, Irvine KD, Carroll SB: Cell recognition, signal induction, and
symmetrical gene activation at the dorsal-ventral boundary of the
developing Drosophila wing. Cell 1995, 82:795-802. 
16. Klein T, Martinez-Arias A: Interactions among Delta, Serrate and
Fringe modulate Notch activity during Drosophila wing
development. Development 1998, 125:2951-2962. 
17. Barrantes IB, Elia AJ, Wunsch K, De Angelis MH, Mak TW, Rossant J,
et al.: Interaction between Notch signalling and Lunatic fringe
during somite boundary formation in the mouse. Curr Biol 1999,
9:470-480. 
18. Evrard YA, Lun Y, Aulehla A, Gan L, Johnson RL: Lunatic fringe is an
essential mediator of somite segmentation and patterning.
Nature 1998, 394:377-381. 
19. Zhang N, Gridley T: Defects in somite formation in lunatic
fringe-deficient mice. Nature 1998, 394:374-377. 
20. McGrew MJ, Dale JK, Fraboulet S, Pourquie O: The lunatic fringe
gene is a target of the molecular clock linked to somite
segmentation in avian embryos. Curr Biol 1998, 8:979-982. 
21. Cohen B, Bashirullah A, Dagnino L, Campbell C, Fisher WW, Leow CC,
et al.: Fringe boundaries coincide with Notch-dependent patterning
centres in mammals and alter Notch-dependent development in
Drosophila. Nat Genet 1997, 16:283-288. 
Research Paper  Evidence that Fringe is a glycosyltransferase Munro and Freeman    819
22. Laufer E, Dahn R, Orozco OE, Yeo CY, Pisenti J, Henrique D, et al.:
Expression of Radical fringe in limb-bud ectoderm regulates
apical ectodermal ridge formation. Nature 1997, 386:366-373. 
23. Rodriguez-Esteban C, Schwabe JW, De La Pena J, Foys B,
Eshelman B, Belmonte JC: Radical fringe positions the apical
ectodermal ridge at the dorsoventral boundary of the vertebrate
limb. Nature 1997, 386:360-366. 
24. Ju BG, Jeong S, Bae E, Hyun S, Carroll SB, Yim J, et al.: Fringe
forms a complex with Notch. Nature 2000, 405:191-195. 
25. Johnston SH, Rauskolb C, Wilson R, Prabhakaran B, Irvine KD, Vogt TF:
A family of mammalian Fringe genes implicated in boundary
determination and the Notch pathway. Development 1997,
124:2245-2254. 
26. Wu JY, Wen L, Zhang WJ, Rao Y: The secreted product of Xenopus
gene lunatic Fringe, a vertebrate signaling molecule. Science
1996, 273:355-358. 
27. Yuan YP, Schultz J, Mlodzik M, Bork P: Secreted fringe-like signaling
molecules may be glycosyltransferases. Cell 1997, 88:9-11. 
28. Brand AH, Perrimon N: Targeted gene expression as a means of
altering cell fates and generating dominant phenotypes.
Development 1993, 118:401-415. 
29. Stanley H, Botas J, Malhotra V: The mechanism of Golgi segregation
during mitosis is cell type-specific. Proc Natl Acad Sci USA 1997,
94:14467-14470. 
30. Rabouille C, Kuntz DA, Lockyer A, Watson R, Signorelli T, Rose DR,
et al.: The Drosophila GMII gene encodes a Golgi alpha-
mannosidase II. J Cell Sci 1999, 112:3319-3330. 
31. Schweitzer R, Howes R, Smith R, Shilo B-Z, Freeman M: Inhibition of
Drosophila EGF receptor activation by the secreted protein Argos.
Nature 1995, 376:699-702. 
32. Zhu G, Allende ML, Jaskiewicz E, Qian R, Darling DS, Worth CA, et al.:
Two soluble glycosyltransferases glycosylate less efficiently
in vivo than their membrane bound counterparts. Glycobiology
1998, 8:831-840. 
33. Colley KJ, Lee EU, Adler B, Browne JK, Paulson JC: Conversion of a
Golgi apparatus sialyltransferase to a secretory protein by
replacement of the NH2-terminal signal anchor with a signal
peptide. J Biol Chem 1989, 264:17619-17622. 
34. Wiggins CAR, Munro S: Activity of the yeast MNN1 α-1,3-
mannosyltransferase requires a motif conserved in many other
families of glycosyltransferases. Proc Natl Acad Sci USA 1998,
95:7945-7950. 
35. Gastinel LN, Cambillau C, Bourne Y: Crystal structures of the
bovine β4galactosyltransferase catalytic domain and its
complex with uridine diphosphogalactose. EMBO J 1999,
18:3546-3557. 
36. Colley KJ: Golgi localization of glycosyltransferases: more
questions than answers. Glycobiology 1997, 7:1-13. 
37. Bretscher MS, Munro S: Cholesterol and the Golgi apparatus.
Science 1993, 261:1280-1281. 
38. Campbell JA, Davies GJ, Bulone V, Henrissat B: A classification of
nucleotide-diphospho-sugar glycosyltransferases based on
amino acid sequence similarities. Biochem J 1997, 326:929-939. 
39. Harris RJ, Spellman MW: O-linked fucose and other post-
translational modifications unique to EGF modules. Glycobiology
1993, 3:219-224. 
40. Moloney DJ, Shair LH, Lu FM, Xia J, Locke R, Matta KL, et al.:
Mammalian Notch1 is modified with two unusual forms of
O-linked glycosylation found on epidermal growth factor-like
modules. J Biol Chem 2000, 275:9604-9611. 
41. Wang Y, Spellman MW: Purification and characterization of a
GDP-fucose:polypeptide fucosyltransferase from Chinese hamster
ovary cells. J Biol Chem 1998, 273:8112-8118. 
42. Rebay I, Fleming RJ, Fehon RG, Cherbas L, Cherbas P,
Artavanis-Tsakonas S: Specific EGF repeats of Notch mediate
interactions with Delta and Serrate: implications for Notch as a
multifunctional receptor. Cell 1991, 67:687-699. 
43. de Celis JF, Bray SJ: The Abruptex domain of Notch regulates
negative interactions between Notch, its ligands and Fringe.
Development 2000, 127:1291-1302. 
44. Lawrence PA, Johnston P: Pattern formation in the Drosophila
embryo: allocation of cells to parasegments by even-skipped and
fushi tarazu. Development 1989, 105:761-767. 
45. Kimmel BE, Heberlein U, Rubin GM: The homeo domain protein
rough is expressed in a subset of cells in the developing
Drosophila eye where it can specify photoreceptor cell subtype.
Genes Dev 1990, 4:712-727. 
46. Orengo A, Maness P: Pyrimidine nucleoside monophosphate
kinase from rat liver and rat Novikoff ascites hepatoma (EC
2.7.4.14). Methods Enzymol 1978, 51:321-331. 
47. Haltiwanger RS, Blomberg MA, Hart GW: Glycosylation of nuclear
and cytoplasmic proteins. Purification and characterization of a
uridine diphospho-N-acetylglucosamine:polypeptide beta-N-
acetylglucosaminyltransferase. J Biol Chem 1992, 267:9005-9013. 
820 Current Biology Vol 10 No 14
Because Current Biology operates a ‘Continuous Publication
System’ for Research Papers, this paper has been published
on the internet before being printed. The paper can be
accessed from http://biomednet.com/cbiology/cub — for
further information, see the explanation on the contents page.
